To: Charger who wrote (20 ) 5/7/1998 11:59:00 AM From: Mr. Miller Read Replies (1) | Respond to
It was $5.00 and has slowly decreased in value. I believe this to be due to the fact that the deal with TISS(though signed in November) was not to be operational until March, initially. The period in between was used for beta testing of the product-basically development testing stage. Well, financing took longer than expected because of this dropping in price because of the lack of activity due to testing, and this delayed the startup with TISS. It would be similar to the effect on ENMD between now and making their drugs available to cancer patients. Testing stage is boring because noone knows if it will work, but when it is done, then it is time to move forward. Testing was completed and the stock stabilized at a low level(unfortunately) for the private placement. The PP was for $310,000 on 1 million shares, so the total shares outstanding is now 11 million and the float is about 3 million.
